Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b53290ef881bc16e92cfbaf0cd9605a7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 |
filingDate |
2005-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64fd04a5cdcc9c66410d32896af5faf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6d58a27f731e22f7d28f18ae71baba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9fdcf1269824f6e4c051ca7ec6343b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24eafa252c7c16471eefef9e3565e157 |
publicationDate |
2008-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1732469-A4 |
titleOfInvention |
BIORESORBABLE ENDOPROSTHESIS WITH RESERVOIRS OF BENEFICIAL AGENTS |
abstract |
A bioresorbable drug delivery stent includes a substantially cylindrical expandable stent formed of a bioresorbable material and a plurality of reservoirs or openings formed in the stent containing a beneficial agent matrix comprising a bioresorbable material and drug. The bioresorbable stent material can be a bioresorbable metal alloy, a bioresorbable polymer, or other bioresorbable material which has sufficient structural integrity to support a lumen, such as a blood vessel lumen for a predetermined period of time. The reservoirs containing the beneficial agent matrix allow delivery of the beneficial agent, such as an anti-restenotic drug, for an administration period which is generally equal to or less than a time that the bioresorbable stent is retained in the lumen. The beneficial agent matrix may include one or more bioresorbable polymers in combination with one or more therapeutic agents or drugs and the structure of the beneficial agent matrix can be programmed to achieve a desired release profile for the drug(s) and a desired administration period. |
priorityDate |
2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |